Riskpilot← Back to searchSign inGet full accessRETSCREEN AS
ASActiveOrg 922436029Sjøgata 8, 8006 BodøOther human health activities n.e.c. · NACE 8699Est. 20195 employees
Revenue 2024
NOK 3,3M
-3% vs 2023
EBITDA margin
9.3%
-68% vs 2023
Equity ratio
58.5%
Financial strength
Net profit 2024
NOK 231K
-68% vs 2023
| Revenue | NOK 3,3M | -3% |
| EBITDA | NOK 306K | -68% |
| Net profit | NOK 231K | -68% |
| Total assets | NOK 3,1M | +10% |
| Equity | NOK 1,8M | +15% |
| Employees | 5 | — |
Legal name
RETSCREEN AS
Org number
922436029
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
22. mars 2019
Share capital
NOK 133 300
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikle og drifte teknologiske løsninger som skal sørge for telemedisinsk oppfølging av pasienter med diabetes mellitus med desentralisert foto av netthinne etter nasjonale retningslinjer. Opplæring og kursing av personell for drift av systemet. Investere i medisinsk teknisk utstyr og tekniske løsninger som kreves samt alt som naturlig hører inn under dette.
Address
Sjøgata 8, 8006 Bodø
Phone
+4791922770
Email
post@retscreen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 675 | 1 072 | 2 007 | 3 394 | 3 307 |
| Staff expenses | −0 | −163 | −374 | −846 | −964 | −1 087 |
| EBITDA | −10 | 109 | 266 | 212 | 949 | 306 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −10 | 109 | 266 | 212 | 949 | 306 |
| Net financials | 0 | 0 | 0 | −29 | −16 | −10 |
| Profit before tax | −10 | 109 | 266 | 183 | 933 | 296 |
| Tax | −0 | 22 | 59 | 40 | 205 | 65 |
| Net profit | −10 | 87 | 208 | 142 | 728 | 231 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 187 | 809 | 1 586 | 1 967 | 2 809 | 3 085 |
| Equity | 110 | 497 | 705 | 847 | 1 575 | 1 806 |
| Long-term debt | 0 | 100 | 600 | 630 | 656 | 678 |
| Short-term debt | 77 | 211 | 281 | 490 | 577 | 601 |
| Total debt | 77 | 311 | 881 | 1 120 | 1 233 | 1 279 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20192024
Equity ratio
58.5%
This company
38.2%
Market median
+53% vs market
20192024
Return on equity
12.8%
This company
18.4%
Market median
+30% vs market
20192024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20192024
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
20192024
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-02-23 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Klinikk S As | Company | 45.0% | 45.0% | 2024 |
| Individual | 18.0% | 18.0% | 2024 | |
| Individual | 18.0% | 18.0% | 2024 | |
Higen Holding As | Company | 10.0% | 10.0% | 2024 |
| Individual | 9.0% | 9.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RETSCREEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ståle Leitvoll | Board of Directors | 0 companies |